About: hypertrophic obstructive cardiomyopathy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: hypertrophic obstructive cardiomyopathy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
rdfs:label	hypertrophic obstructive cardiomyopathy (en) 閉塞性肥大型心筋症 (ja) cardiomyopathie hypertrophique obstructive (fr) hipertrofična obstruktivna kardiomiopatija (sl)
skos:prefLabel	hypertrophic obstructive cardiomyopathy (en) 閉塞性肥大型心筋症 (ja) cardiomyopathie hypertrophique obstructive (fr) hipertrofična obstruktivna kardiomiopatija (sl)
name	hypertrophic obstructive cardiomyopathy (en) 閉塞性肥大型心筋症 (ja) cardiomyopathie hypertrophique obstructive (fr) hipertrofična obstruktivna kardiomiopatija (sl)
instance of	wds:Q55065467-79a49e33-45a0-dde8-9d1d-a83d7f5af100
instance of	disease
subclass of	wds:Q55065467-2b9ff0a7-4e53-e381-b8d4-f604663e474f
subclass of	hypertrophic cardiomyopathy
skos:altLabel	HOCM (en) asymmetric septal hypertrophy (en) idiopathic hypertrophic subaortic stenosis (en)
UMLS CUI	wds:Q55065467-392afa63-42fe-9034-c2c9-f966a0478292
ICD-11 ID (MMS)	wds:Q55065467-a3e792c7-df0e-443d-aca9-83a01f716bcd
ICD-11 (foundation)	wds:Q55065467-1B61726E-D844-48FA-881F-2802C55895E4
UMLS CUI	CL495870
ICD-11 ID (MMS)	BC43.12
ICD-11 (foundation)	393452470
possible medical findings	wds:Q55065467-e2be9387-43de-ee79-0ba7-ad4cca4c0759
possible medical findings	systolic ejection murmur
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q55065467
is main subject of	Treatment of hypertrophic obstructive cardiomyopathy with verapamil Fixed left ventricular outflow tract obstruction in presumed hypertrophic obstructive cardiomyopathy: implications for therapy Hypertrophic obstructive cardiomyopathy due to Fabry's disease The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes Treatment modalities in hypertrophic obstructive cardiomyopathy: surgical myectomy versus percutaneous septal ablation. Asymmetric septal hypertrophy and sympathetic overactivity in normotensive hemodialyzed patients. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up. PIC study group. Pacing In Cardiomyopathy Symptomatic hypertrophic obstructive cardiomyopathy: the role of dual-chamber pacing Morbidity outcome in patients with hypertrophic obstructive cardiomyopathy undergoing cardiac septal myectomy: early-extubation anesthesia versus high-dose opioid anesthesia technique Long-term medical management of hypertrophic obstructive cardiomyopathy Hypertrophic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy New treatment methods for patients with hypertrophic obstructive cardiomyopathy Clinical practice. Hypertrophic obstructive cardiomyopathy Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy Mid ventricular obstruction in hypertrophic obstructive cardiomyopathy. New diagnostic and therapeutic challenge Dual chamber pacing for hypertrophic obstructive cardiomyopathy: has its time come? Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy--the Baylor experience (1996-2002). One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Impact of right atrial-left ventricular dual-chamber permanent pacing in patients with severely symptomatic hypertrophic obstructive cardiomyopathy. Dual-chamber pacing in hypertrophic obstructive cardiomyopathy with biventricular outflow tract obstruction and severe drug-refractory symptoms in a 9-year-old girl. Pacing-induced electrophysiological remodeling in hypertrophic obstructive cardiomyopathy--observations on cardiac memory. An equation to predict the changes in peak left ventricular pressure in hypertrophic obstructive cardiomyopathy after treatment: application to the administration of disopyramide. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy Increased sensitivity of left ventricular relaxation to inotropic interventions in patients with coronary artery disease: comparison with normal subjects, mitral stenosis and asymmetric septal hypertrophy Danger of use of disopyramide in patients with hypertrophic obstructive cardiomyopathy. An electrophysiologic study The importance of ventricular septal morphology in the effectiveness of dual chamber pacing in hypertrophic obstructive cardiomyopathy Induced septal infarction: a new therapeutic strategy for hypertrophic obstructive cardiomyopathy Clinical progress after randomized on/off pacemaker treatment for hypertrophic obstructive cardiomyopathy. Pacing in Cardiomyopathy (PIC) Study Group Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic sub Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice Operative treatment of hypertrophic obstructive cardiomyopathy. The case against mitral valve replacement Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl) Modification of atrioventricular conduction as adjunct therapy for pacemaker-treated patients with hypertrophic obstructive cardiomyopathy Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up Delayed occurrence of complete heart block without warning after alcohol septal ablation for hypertrophic obstructive cardiomyopathy Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy Exacerbation of left ventricular outlet obstruction in hypertrophic obstructive cardiomyopathy: an unexpected complication of gastric banding Diffuse angiodysplasia of the upper gastrointestinal tract in a patient with hypertrophic obstructive cardiomyopathy Keynote Lecture-Transmitral hypertrophic obstructive cardiomyopathy (HOCM) repair Extended myectomy for hypertrophic obstructive cardiomyopathy A new concept for correction of systolic anterior motion and mitral valve regurgitation in patients with hypertrophic obstructive cardiomyopathy Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T. Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy Fragmented QRS as a predictor of arrhythmic events in patients with hypertrophic obstructive cardiomyopathy The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy. Experience over 15 years Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy Complete pulmonary vein isolation guided by three-dimensional electroanatomical mapping for the treatment of paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy Long QT syndrome in extensive infective endocarditis complicating hypertrophic obstructive cardiomyopathy. Combined cox maze procedure, septal myectomy, and mitral valve replacement for severe hypertrophic obstructive cardiomyopathy complicated by chronic atrial fibrillation. Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software